NASDAQ: RNAQ
Rainier Acquisition Corp Stock

$10.12-0.06 (-0.59%)
Updated Sep 16, 2026
RNAQ Price
$10.12
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.00
52 Week High
$10.50
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$6.22k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1,388.89
Operating Cash Flow
-$6k
Beta
0.22
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RNAQ Overview

Rainier Acquisition Corporation operates as a blank check company formed for the purpose of effecting a merger, acquisition, or similar business combination. The company intends to focus its search on the global life sciences industries, including therapeutics, diagnostics, genomics, precision medicine, life science tools, and research services.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine RNAQ's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Shell Company

Industry Rating
F
RNAQ
Ranked
#8 of 26

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$10.90C
$10.95C
$13.85C
View Top Shell Company Stocks

Be the first to know about important RNAQ news, forecast changes, insider trades & much more!

RNAQ News

Overview

Due Diligence Score

Industry Average (8)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RNAQ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RNAQ's cash and short-term investments ($19.24k) can cover RNAQ's cash burn for the next year (N/A), after accounting for decreasing cash burn (N/A)
Interest Coverage Financials
RNAQ's short-term liabilities ($25.00k) exceed its short-term assets ($24.98k)
Short-term Liabilities Financials
RNAQ's short-term assets ($24.98k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more RNAQ due diligence checks available for Premium users.

Valuation

RNAQ's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
RNAQ's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$25.0k
Liabilities
$25.0k
Debt to equity
-1,388.89
RNAQ's short-term liabilities ($25.00k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RNAQ's short-term assets ($24.98k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RNAQ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RNAQ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
RNAQ's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RNAQ vs Shell Company Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AACP$236.34M0.00%N/A-42.92x
AAC$499.62M0.00%N/A-116,489.52x
AACI$342.00M0.00%N/A-36.46x
AACO$313.30M0.00%N/A-45.26x
XIIIUN/A-0.42%N/AN/A

Rainier Acquisition Stock FAQ

What is Rainier Acquisition's quote symbol?

(NASDAQ: RNAQ) Rainier Acquisition trades on the NASDAQ under the ticker symbol RNAQ. Rainier Acquisition stock quotes can also be displayed as NASDAQ: RNAQ.

If you're new to stock investing, here's how to buy Rainier Acquisition stock.

What is the 52 week high and low for Rainier Acquisition (NASDAQ: RNAQ)?

(NASDAQ: RNAQ) Rainier Acquisition's 52-week high was $10.50, and its 52-week low was $10.00. It is currently -3.62% from its 52-week high and 1.2% from its 52-week low.

How much is Rainier Acquisition's stock price per share?

(NASDAQ: RNAQ) Rainier Acquisition stock price per share is $10.12 today (as of Sep 16, 2026).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.